This inventor holds 20 USPTO granted patents and 3 published patent applications and 10 EPO patents, primarily in Antibody Therapeutics. Top assignees: Cancer Research Technology Limited, Tusk Therapeutics Ltd., Black Belt Therapeutics Limited. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stevenage, GB (2022 - 2023)
- Hertfordshire, GB (2020 - 2024)
Company Filing History:
12 out of 268 
12 out of 12 
8 out of 8 Years Active: 2020-2026
Areas of Expertise:
Title: Exploring the Contributions of Beatriz Goyenechea Corzo
Introduction
Beatriz Goyenechea Corzo is an influential innovator based in Hertfordshire, Great Britain. With a remarkable portfolio that includes 19 patents, she has made significant strides in the field of biotechnology, particularly in the development of antibody agents for medical applications.
Latest Patents
Among her latest patents, Goyenechea Corzo has developed groundbreaking CD38 modulating antibody agents. These patents provide antibody sequences that specifically bind to human CD38, offering a foundation for fully human monoclonal antibodies and antigen-binding fragments. Such advancements hold promise for medical methods and compositions, especially in the treatment of cancer, showcasing her commitment to enhancing pharmaceutical manufacturing and development.
Career Highlights
Goyenechea Corzo has garnered experience working with reputable organizations such as Tusk Therapeutics Ltd. and Cancer Research Technology Limited. Her work in these companies has contributed to crucial advancements in therapeutic antibody development and cancer research, establishing her reputation as a leading inventor in her field.
Collaborations
Throughout her career, Goyenechea Corzo has collaborated with esteemed professionals such as Anne Goubier and Josephine Salimu. These partnerships have enabled the fusion of ideas and expertise, further driving innovation in the biotechnological landscape.
Conclusion
Beatriz Goyenechea Corzo exemplifies the spirit of innovation in the biopharmaceutical sector. Her work on CD38 modulating antibody agents not only highlights her inventive prowess but also underscores the potential of her contributions to transforming cancer treatment through advanced therapeutic solutions. Her continued dedication to research and development solidifies her position as a pivotal figure in the world of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile